Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

We will continue to evaluate the pharmacokinetic and pharmacodynamic properties of antimalarial drugs in malnourished children, and use modelling and simulation to suggest revised dose regimens. The collaboration with the MSF-site in Niger will continue to gather data in this particularly vulnerable group of patients.